Turbine: Virtual Biology Platform for Drug Discovery
Turbine helps pharmaceutical and biotech companies simulate biological experiments to support oncology drug discovery. It is designed for teams that need to identify biomarkers or optimize antibody-drug conjugate (ADC) payloads.
At a glance
- Category
- Healthcare
- Best for
- Pharmaceutical companies, Biotech companies, Research institutions, Oncology drug discovery teams
- Pricing
- Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
- Key use cases
- ADC Payload Optimization, Biomarker Selection, Combination Therapy Design, Target Discovery and De-risking, Clinical Positioning
- Official website
- turbine.ai
Turbine provides a virtual laboratory environment designed to simulate biological experiments using a mechanistic model called Simulated Cell. The platform is intended for researchers in the biopharma and biotech sectors who need to predict how cancer cells may respond to specific drugs or genetic alterations before moving to wet-lab validation.
The tool provides access to a library of oncology cell lines and payload molecules, supporting in silico simulations to help identify potential targets and design combination therapies. By simulating these interactions, the platform is designed to help researchers narrow down hypotheses for testing in physical labs.
Buyers should confirm which level of the Virtual Lab fits their needs, as the platform offers simulations based on public data as well as custom models using proprietary datasets. It primarily focuses on oncology and ADC optimization.
Key Features
A mechanistic approach that trains virtual cells on signaling parameters to predict drug responses and gene essentiality.
Provides access to 1,400 oncology cell lines for simulation purposes.
A specialized tool designed for the optimization of antibody-drug conjugate payloads.
Allows users to simulate experiments using harmonized public and proprietary datasets.
Supports in silico predictions by leveraging a company's own proprietary datasets and sample libraries.
Supports simulations on virtual endogenous disease models for R&D decision support.
Use Cases
Identifying payload combinations with a likelihood of efficacy in biomarker-positive model populations.
Using in silico pharmacology screens to suggest patient selection hypotheses for specific cancer types.
Predicting synergies between different drug types, such as Topo1i and PARPi, using simulation data.
Identifying potential drug targets and validating their biological potential through virtual simulation.
Supporting the strategy for clinical trials by predicting sensitivity orders of subtypes for specific payloads.
Best For
Pricing
Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
FAQ
Turbine is a virtual biology platform that simulates biological experiments. It uses AI to predict how oncology cell lines may respond to drugs and genetic alterations.
The platform is designed for researchers at pharmaceutical companies, biotech firms, and research institutions focusing on oncology drug discovery.
vLab Core uses public and Turbine-proprietary datasets for simulations, while vLab Custom supports the integration of a user's own proprietary sample libraries and drugs.
Source category: Healthcare
Source subcategory: Machine Learning Platform
